Indication
Growth failure associated with Turner's syndrome
Growth failure associated with Turner's syndrome is a primary skeletal and endocrine manifestation characterized by progressive linear growth deceleration and resultant short stature in female pediatric patients. Read more about Growth failure associated with Turner's syndrome
11 drugs 6 manufacturers
Drugs that treat it
Common Growth failure associated with Turner's syndrome therapies.
GENOTROPIN (somatropin)
HUMATROPE (somatropin)
HUMATROPE (somatropin)
NORDITROPIN FLEXPRO (somatropin)
NORDITROPIN FLEXPRO (somatropin)
ZOMACTON (somatropin)
NUTROPIN AQ NUSPIN (somatropin)
GENOTROPIN (somatropin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGrowth failure associated with Turner's syndrome is a primary skeletal and endocrine manifestation characterized by progressive linear growth deceleration and resultant short stature in female pediatric patients.
The underlying genetic disorder involves complete or partial monosomy of the X chromosome (most commonly 45,X or mosaic variants).
This leads to haploinsufficiency of the short-stature homeobox (SHOX) gene, impairing chondrocyte proliferation and longitudinal bone development.
The clinical state typically manifests in infancy or early childhood with slowing growth velocity, an absence of the normal pubertal growth spurt due to concomitant gonadal dysgenesis, and an untreated adult height well below genetic potential.
- nih.gov
Growth failure associated with Turner's syndrome is a primary skeletal and endocrine manifestation characterized by progressive linear growth deceleration and resultant short stature in female pediatric patients The underlying genetic disorder involves complete or partial monosomy of the X chromosome (most commonly 45,X or mosaic variants) The clinical state typically manifests in infancy or early childhood with slowing growth velocity, an absence of the normal pubertal growth spurt due to conco...
- nih.gov
Growth failure associated with Turner's syndrome is a primary skeletal and endocrine manifestation characterized by progressive linear growth deceleration and resultant short stature in female pediatric patients
- nih.gov
The underlying genetic disorder involves complete or partial monosomy of the X chromosome (most commonly 45,X or mosaic variants) The clinical state typically manifests in infancy or early childhood with slowing growth velocity, an absence of the normal pubertal growth spurt due to concomitant gonadal dysgenesis, and an untreated adult height well below genetic potential
- medlineplus.gov
This leads to haploinsufficiency of the short-stature homeobox (SHOX) gene, impairing chondrocyte proliferation and longitudinal bone development
- turnersyndromefoundation.org
This leads to haploinsufficiency of the short-stature homeobox (SHOX) gene, impairing chondrocyte proliferation and longitudinal bone development
- turnersyndrome.org
The clinical state typically manifests in infancy or early childhood with slowing growth velocity, an absence of the normal pubertal growth spurt due to concomitant gonadal dysgenesis, and an untreated adult height well below genetic potential
Personalize your experience
Follow Growth failure associated with Turner's syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.